HealthEquity (NASDAQ:HQY) Hits New 12-Month High – Here’s Why

HealthEquity, Inc. (NASDAQ:HQY)’s stock price hit a new 52-week high during mid-day trading on Wednesday . The company traded as high as $106.42 and last traded at $104.79, with a volume of 49197 shares traded. The stock had previously closed at $104.97.

Analysts Set New Price Targets

HQY has been the topic of several research analyst reports. BMO Capital Markets raised shares of HealthEquity from a “market perform” rating to an “outperform” rating and raised their target price for the stock from $85.00 to $105.00 in a research report on Thursday, April 9th. Royal Bank Of Canada upped their price objective on HealthEquity from $100.00 to $108.00 and gave the stock an “outperform” rating in a report on Wednesday, June 3rd. Citigroup reissued a “market outperform” rating on shares of HealthEquity in a research report on Monday, June 1st. Weiss Ratings raised HealthEquity from a “hold (c)” rating to a “hold (c+)” rating in a research note on Friday, June 5th. Finally, Citizens Jmp raised their price target on shares of HealthEquity from $110.00 to $111.00 and gave the company a “market outperform” rating in a report on Monday, June 1st. Eleven analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $110.93.

HealthEquity Price Performance

The company has a market cap of $8.65 billion, a price-to-earnings ratio of 38.74, a P/E/G ratio of 1.76 and a beta of 0.21. The company’s 50-day simple moving average is $93.03 and its 200-day simple moving average is $85.66. The company has a debt-to-equity ratio of 0.46, a current ratio of 3.44 and a quick ratio of 3.44.

HealthEquity (NASDAQ:HQY) last released its quarterly earnings results on Thursday, May 28th. The company reported $1.24 earnings per share for the quarter, beating analysts’ consensus estimates of $1.11 by $0.13. HealthEquity had a net margin of 17.25% and a return on equity of 14.75%. The business had revenue of $354.64 million during the quarter, compared to analyst estimates of $352.02 million. HealthEquity’s revenue was up 7.2% on a year-over-year basis. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. On average, equities research analysts anticipate that HealthEquity, Inc. will post 3.92 EPS for the current year.

Insider Buying and Selling

In other news, EVP Delano Ladd sold 7,500 shares of the stock in a transaction that occurred on Thursday, May 28th. The stock was sold at an average price of $90.00, for a total transaction of $675,000.00. Following the completion of the transaction, the executive vice president directly owned 91,141 shares in the company, valued at approximately $8,202,690. This represents a 7.60% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Michael Henry Fiore sold 3,142 shares of the company’s stock in a transaction on Friday, May 29th. The shares were sold at an average price of $95.00, for a total transaction of $298,490.00. Following the completion of the sale, the executive vice president directly owned 59,113 shares in the company, valued at $5,615,735. This represents a 5.05% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders have sold 17,905 shares of company stock worth $1,651,280. 1.60% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On HealthEquity

Institutional investors have recently modified their holdings of the stock. Mitsubishi UFJ Asset Management Co. Ltd. acquired a new position in HealthEquity in the second quarter worth about $193,000. Global Retirement Partners LLC bought a new stake in shares of HealthEquity in the 2nd quarter valued at approximately $305,000. Bank of New York Mellon Corp bought a new position in HealthEquity during the second quarter worth $60,177,000. Private Advisory Group LLC acquired a new position in HealthEquity in the second quarter worth $234,000. Finally, Focus Partners Advisor Solutions LLC bought a new stake in HealthEquity during the second quarter valued at $211,000. Institutional investors and hedge funds own 99.55% of the company’s stock.

HealthEquity Company Profile

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.